Special Issue "Liposome Technologies"
A special issue of Pharmaceutics (ISSN 1999-4923).
Deadline for manuscript submissions: closed (30 June 2013)
This special issue “Liposome Technologies” will deal with all aspects of liposome-mediated delivery of therapeutic agents. Therapeutic agents may include drugs, or any biological agents including DNA, RNA, proteins, or antigens for vaccination. The mode of delivery may be passive or ligand-mediated targeting, controlled release, or systemic localization. The topic of papers can be the preparation of novel formulations, study of their properties, the in vivo or in vitro testing of such agents for their efficacy or stability, or study of their localization within cells in vitro or in vivo. In addition to papers that focus directly on therapeutic applications, studies dealing with the fundamental aspects of liposomes of concern for their use in drug delivery will also be considered.
Dr. Timothy D. Heath
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. Papers will be published continuously (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are refereed through a peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed Open Access quarterly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 550 CHF (Swiss Francs). English correction and/or formatting fees of 250 CHF (Swiss Francs) will be charged in certain cases for those articles accepted for publication that require extensive additional formatting and/or English corrections.
- drug delivery
- cationic lipids
- gene delivery
- controlled release
- liposome targeting
- liposome-mediated therapeutics
- membrane permeability
- liposome-based vaccines